Formation Venture Engineering — Full Portfolio
12 tracked investments · listed companies and verified rows first
Adeptrix develops the exoBAMS platform, using antibody-based immunoaffinity capture of extracellular vesicles combined with MALDI mass spectrometry to profile proteins, lipids, metabolites and other molecules from a single blood sample.
AI & Machine LearningBiotechMedical Devices
Akston Biosciences develops protein-based therapies for pets to support veterinary care and improve treatment accessibility.
BiotechHealthtechBeverly, US
Todd C. Zion(Executive Officer, Director)James Herriman(Executive Officer)Robyn Davis(Director)Lovick E. Cannon(Director)Thomas M. Lancaster(Executive Officer, Director)
Reimagining hospital beds as diagnostic and therapeutic devices; sensor-cell technology monitors airflow, pressure, and skin health to prevent and heal bedsores.
LeviSense Medical is a Massachusetts-based medical device company developing next-generation technology for therapeutic beds used in wound care.
HardwareHealthtechMedical DevicesBeverly, US
David Bertoni(Executive Officer, Director)Michael McGarrity(Director)Peter Rock(Chief Financial Officer)Donald Dye(Director)Dave Bertoni(COO & Co-Founder)Shri Parikh(CEO & Director)
NeuroDex is a biotechnology company that develops biomarkers and diagnostic solutions for neurological disorders using neuron-derived extracellular vesicle (NDE) panels.
BiotechDigital HealthMedical Devices
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
AI & Machine LearningBiotechDeep Tech
Builds scalable platforms for oligo synthesis and conjugation to support diagnostics and therapeutics.
Developing a precision immunotherapy approach to Alzheimer's, chronic pain, and neurodegenerative diseases; first graduate of FVE Foundry.
TWL Bio develops an immunotherapy platform that trains the immune system to target pathological proteins driving chronic, lifelong conditions, positioned as an alternative to costly monoclonal antibody infusions.
BiotechDeep TechHealthtech
Developer of Fc-fusion-based vaccines and boosters for infectious diseases, offering durable safety, broad-spectrum immunity, and room-temperature stability for global access.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.